Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

March 7, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • India
  • COVID UPDATE: Indian genes against the coronavirus

Heparin sulfate: the key to coronavirus infection

Another cause of Hepatocellular Carcinoma (HCC) apart from alcoholism

COVID UPDATE: Indian genes against the coronavirus
  • India

COVID UPDATE: Indian genes against the coronavirus

bioxone September 18, 2020September 18, 2020

-Binayak Das, Team bioXone

A team of scientists claims that Indians should be grateful to their genetics, which according to their study is a critical factor in having a comparatively lesser number of deaths from COVID-19 in their populations. They studied the complete DNA data of the ACE2 gene in the X chromosomes from different continental populations. In their study published in PLOS ONE, the mention probable reasons for lower mortality rates were observed amongst Indian populations against US or European populations.

In their study, they conducted a haplotype-based analysis of the ACE2 gene, to study all of its possible genetic mutations in great depth. They found that certain mutations are possibly helping the South and East Asian populations by improving their resistance against the novel coronavirus, leading to a lower number of fatalities. The similarity in the DNA fragments between the South Asian and East Asian populations was found to be significantly similar, which might explain the lower mortality rate observed in both of these populations. They reported two major mutations of the ACE2 gene which were found to be responsible for improving the entry point of the virus, to be of key importance in establishing the resistance.

The team composed of Rudra Pandey and Prajwal Singh from BHU, Avinash Rasalkar, Pankaj Srivastava from Sagar Central University, Rakesh Tamang from Calcutta University and Pramod Kumar from National Centre for Disease Control (NCDC), Prof. George van Driem of University of Bern, Switzerland, and others believe that their study will help researchers to better understand the patterns of transmission of the deadly virus.

Source:  Anshika Srivastava, Rudra Kumar Pandey, Pramod Kumar, Avinash Arvind Rasalkar, Rakesh Tamang, Pankaj Shrivastava, Gyaneshwer Chaubey, Most frequent South Asian haplotypes of ACE2 share identity by descent with East Eurasian populations, Evolutionary Genetics 10.21203/rs.3.rs-27310/v1 Link- https://www.researchsquare.com/article/rs-27310/v1

For more news please visit https://bioxone.in//

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged ACE2 ACE2 receptor BHU calcutta university Covid covid cases in india COVID INDIA covid status india lower mortality rate mutations of the ACE2

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • World

Another cause of Hepatocellular Carcinoma (HCC) apart from alcoholism

bioxone September 18, 2020

-Sristi Raj Rai, Amity University Kolkata Alcohol consumption is not always the cause of hepatocellular carcinoma (HCC). People who drink little or no amount of alcohol can also develop a symptomless condition named non-alcoholic fatty liver disease (NAFLD), resulting from excessive storage of fats in liver cells that are now common among the masses. An […]

Hepatocellular Carcinoma

Related Post

  • BiotechToday
  • India

SIGN TO START PHASE 1 HUMAN TRIAL OF “ANTISERA”-DCGI

bioxone October 7, 2020October 7, 2020

Aishila Kar, Amity University Kolkata ICMR officials said on Tuesday that The Drugs Controller General of India has given authorization for conducting Phase-1 human clinical trial for an “antisera” that was developed by injecting inactivated SARS-CoV-2 in horses and can be a treatment for COVID-19. The Indian Council of Medical Research (ICMR) in alliance with a Hyderabad-based vaccine maker […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • FEATURED
  • India
  • Latest

A Green way to combat Breast Cancer

bioxone September 6, 2020September 6, 2020

–Biswadeep Sen, Amity University Kolkata Breast cancer is one of the most common diseases found in the modern day. Luckily, a novel aspect is now coming into light in-order to combat the seemingly impossible disease. The Auric Nanoparticles, are the new devices that are being heavily relied on for many biomedical aspects. More importantly, a […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • FEATURED
  • India
  • Latest
  • World

COVID UPDATE: AstraZeneca’s Covid-19 vaccine trials put on hold by Serum Institute

bioxone September 10, 2020September 10, 2020

–Anuska Sen, Team bioXone While the entire nation unanimously waits for India’s Covid-19 vaccine, there are various drawbacks and negativities regarding the vaccine that keeps on upsetting the world, particularly Indians. However, another disheartening news has been reported today. AstraZeneca’s Covid-19 vaccine has been paused by its partner, the Serum Institute of India. Earlier this […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy